ArticleEuropean journal of case reports in internal medicine2026

Bleeding Disorder, A Newly Recognized Adverse Event Following Sacubitril/Valsartan Therapy.

Yaser W Al-Omari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.